<unk>  is a long-acting human insulin analog that is FDA approved for the {{{indicationType}}} of to improve glycemic control in patients 1 year of age and older with diabetes mellitus..   Common adverse reactions include hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, rash, edema and weight gain..
Insulin degludec
Insulin aspart
Insulin glulisine
Insulin detemir
Insulin lispro
Insulin glargine
Exenatide
Liraglutide